Skip to main content
Clinical Trials/IRCT20210519051345N22
IRCT20210519051345N22Recruiting未知

Bioequivalence study of Tadalafil 5mg tablet manufactured by Arya Co. compared with innovator product

Tabriz University of Medical Sciences0 sites24 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Enrollment
24

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
19 years to 59 years (—)
Sex
Male

Inclusion Criteria

  • General Health (in terms of Liver, Heart and Kidney)

Exclusion Criteria

  • History of cardiovascular disease, liver and kidney disease
  • Alcohol and drug addiction
  • History of drug allergy

Investigators

Similar Trials

Not yet recruiting
Phase 4
Bioequivalence study of tadalafil 5 mg film-coated tablet in Thai healthy volunteersThai healthy male subjects &#44Aged 18 †50 years &#44BMI were within 18&#4525 kg/m2 &#44Good health confirming by physical and clinical
TCTR20190806005Faculty of Medicine, Chulalongkorn University60
Recruiting
Not Applicable
In-vivo Bioequivalence study of Tadalafil tablet with brand drugs (CIALIS Lilly USA)
IRCT20200105046010N39Mofid Pharmaceutical Co.24
Recruiting
Phase 3
The effect of oral vitamin D on erectile dysfunctioMale erectile dysfunction.Male erectile dysfunction
IRCT20151123025202N34Hamedan University of Medical Sciences122
Active, not recruiting
Phase 4
The effect of tadalafil in the treatment of erectile dysfunction in patients with chronic renal failureerectile dysfunctionend stage renal diseasehaemodialysiskidney transplantRenal DialysisKidney TransplantationErectile DysfunctionKidney Failure, Chronic
TCTR20220310008rology-Nephrology Research Center of Shahid Beheshti University of Medical Sciences45
Completed
Not Applicable
The effect of tadalafil compared to tamsulosin and placebo on the symptoms of double-J stent insertion in men with ureter stonesCondition 1: Lower urinary tract symptoms. Condition 2: Pain in the flank and suprapubic areas. Condition 3: Sexual function.Calculus of lower urinary tractOther and unspecified abdominal painUnspecified sexual dysfunction, not caused by organic disorder or disease
IRCT201702261853N13rology Research Centre, Guilan University of Medical Sciences120